Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Idris Abdalli
Observed name:
I Abdalli
Observed institution:
University of Algiers Benyoucef Benkhedda
OpenAlex ID:
A5115629254
EE731 Therapeutic Drug Monitoring and Selective Use of Glucarpidase in High-Dose Methotrexate Therapy: A Cost Analysis From the Algerian Payer Perspective
2025
·
Farida Bouchenak
, Nardjess Rim Laoufi
, et al.
·
Value in Health
EE105 Budget Impact of Azathioprine Metabolite Monitoring in Crohn’s Disease in Algeria
2025
·
Farida Bouchenak
, Nardjess Rim Laoufi
, et al.
·
Value in Health
EE572 Pharmaco-Economic Evaluation of Therapeutic Drug Monitoring of 5-Fluorouracil in the Treatment of Colorectal Cancer
2024
·
F Bouchenak
, NR Laoufi
, et al.
·
Value in Health
EE401 Budgetary Impact of Pre-Therapeutic DPD Deficiency Screening in Fluoropyrimidine-Treated Cancer Patients in Algeria
2024
·
F Bouchenak
, NR Laoufi
, et al.
·
Value in Health
PDF
EE228 Economic Impact of the Introduction of Combined Triple Therapy Budesonide/Glycopyrronium/Formoterol in the Continuous Treatment of Chronic Obstructive Pulmonary Disease in Algeria
2024
·
F Bouchenak
, C Bourouis
, et al.
·
Value in Health
PDF
EE264 Medico-Economic Benefit of Dihydropyrimidine Dehydrogenase Screening in the Colorectal Cancer Treatment Using Fluoropyrimidines in Algeria
2024
·
K Mansouri
, N Ramdani
, et al.
·
Value in Health
Show more works
View as search
Works count:
6
Citation count:
H-index:
I10-index:
Year
Topic
Type
